跳至主要内容
临床试验/KCT0008087
KCT0008087招募中未知

Single center, randomized, prospective, comparative study to evaluate the efficacy and safety according to type of ADM(acellular dermal matrix) when being applied for reconstruction of defect areas after breast conserving surgery in breast cancer patients

Inje University Busan Paik Hospital0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 70(Year)(—)
性别
Female

入选标准

  • All subjects can participate in the clinical trial only when all of the following criteria are met.
  • ? Those aged over 20 years old and up to 70 years old
  • ? Patients with histopathologically confirmed breast cancer
  • ? The patients planning to undergo breast conserving surgery with MegaDerm(diced type or sheet type) where being applied for reconstruction of defect areas

排除标准

  • If any of the following items apply, the subject is excluded from the clinical trial.
  • ? In case of mastectomy additionally because of local recurrent after breast conserving surgery
  • ? Who underwent total mastectomy
  • ? Uncontrolled severe infection
  • ? Autoimmune disease
  • ? Coagulation disorder (it is possible be enrolled, if the patients take the Aspirin or Plavix)
  • ? Other patients who were judged to be difficult to participate in this study by the investigator

研究者

相似试验